中国旭阳(01907.HK):争取5年内焦炭业务量提升至3,000万吨
中国旭阳(01907.HK)主席兼行政总裁杨雪岗表示,未来5年目标将主要焦炭业务量扩张到3,000万吨,同时继续拓展焦化企业运营管理业务,提高市场占有率及议价能力。
上半年公司纯利按年减少58.3%,主要由於2月至4月焦炭产品价格下跌,导致价差收窄。市场管理部副总经理高新奇解释,7月市场出现供不应求情况,目前价格已有所回升,预料明年内地基建推动需求上升,加上全国去产能下供应减少,预期价格将自今年第四季价格起继续稳中有升。
今年上半年旭阳资本开支达约12.8亿元人民币(下同),当中有约10亿元用於3个固定资产项目的工程,料下半年再需要投入约10亿元。他强调经营现金流可覆盖,亦会寻找长期项目贷款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.